Company Overview and News

 
MGIC Investment's (MTG) CEO Pat Sinks on Q1 2018 Results - Earnings Call Transcript

17h seekingalpha
Good morning, my name is Felicia and I will be your conference operator today. At this time I would like to welcome everyone to the MGIC Investment Corporation First Quarter Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers remarks there will be a question-and-answer session. [Operator Instructions]. Thank you. Mr. Mike Zimmerman, Senior Vice President of Investor Relations, you may begin your conference.

 
Term CEF Ladder #2: Mortgage Closed-End Funds Explored

2018-04-18 seekingalpha
This is the second installation in a series of planned articles exploring the concept of a Term CEF Ladder.

 
The Fed Is Making 2 Huge Mistakes

2018-04-17 seekingalpha
The impact of "slow growth forever" means that the Fed shouldn't be normalizing anywhere near as fast as they are.

 
Doug Duncan: Even U.S. Government Economists Predict Trouble Ahead

2018-04-17 seekingalpha
The chief economist for Fannie Mae (OTCQB:FNMA) is surprisingly outspoken about the troublesome outlook for the US economy. He's worried about the rising cost of debt service as outstanding credit continues to mount at the same time interest rates are starting to ratchet higher, too.

 
ServisFirst Bancshares' (SFBS) CEO Tom Broughton on Q1 2018 Results - Earnings Call Transcript

2018-04-17 seekingalpha
Good afternoon and welcome to the ServisFirst Bancshares’ Inc. First Quarter Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today's presentation there will be an opportunity to ask questions. [Operator Instructions] Please note this event is being recorded.

 
AGNC Investment's Q1 2018 Income Statement And Earnings Preview - Part 3 (Notable MBS Price Decreases)

2018-04-16 seekingalpha
I am projecting AGNC will report a combined notable net unrealized loss on available-for-sale securities and investment securities measured at FMV for the first quarter of 2018.

 
Buffett 1994 Lecture – ValueWalk Premium

2018-04-15 valuewalkpremium
Testing. One million, two million, three million… Somebody yelled out from the back, earlier, “I can’t hear you.” I was giving a speech a few weeks ago and the same thing happened. Somebody said, ”I can’ t hear you.” And, then someone in the front stood up and said, ”I can- Let’s change places”

 
Housing: Part 292 - Dodd-Frank Was An Unprecedented Assault On Working Class Homeowners

2018-04-15 seekingalpha
I have put together a new measure that helps to focus on the effects of credit collapse on home prices. I have graphed the relative prices of the median homes in each zip code in the top 20 metro areas. I split each MSA into 5 quintiles by median home price. Then, over time, I compare the relative change in those prices indexed to the year 2000 (Quintile 5 divided by Quintile 1).

 
Annaly Is A Good Income Investment

2018-04-15 seekingalpha
Annaly is a mortgage agency REIT, but has diversified its business and has now a better profile than peers.

1
Crisis to Recovery Timeline | Annual Report 2017 | St. Louis Fed

2018-04-14 stlouisfed.org
Geared to a Main Street audience, this e-newsletter will provide a sampling of the latest speeches, research, podcasts, videos, lesson plans and much more. Sign up now to have this emailed to you monthly at no charge.

1
A Policymaker's Reflections | Annual Report 2017 | St. Louis Fed

2018-04-13 stlouisfed.org
Geared to a Main Street audience, this e-newsletter will provide a sampling of the latest speeches, research, podcasts, videos, lesson plans and much more. Sign up now to have this emailed to you monthly at no charge.

 
mREIT Top Buy: 11.56% Yield, 20% Upside, Safe Haven, Strong Insider Buying, Solid Cash Flow

2018-04-13 seekingalpha
The entire REIT sector has been devastated by the fear of rising interest rates. Annaly is down 12% year-to-date.

 
Why the Fed Pays Interest on Banks’ Reserves | St. Louis Fed

2018-04-11 stlouisfed.org
Geared to a Main Street audience, this e-newsletter will provide a sampling of the latest speeches, research, podcasts, videos, lesson plans and much more. Sign up now to have this emailed to you monthly at no charge.

 
LIBOR And SOFR: Buy-Side, Take Over

2018-04-11 seekingalpha
Why is it so hard to find a three-month interest rate to replace the fallen LIBOR?

 
Mortgage refinances fall to the lowest level in a decade

2018-04-11 cnbc
Total mortgage application volume fell 1.9 percent, seasonally adjusted, from the previous week, according to the Mortgage Bankers Association. Volume was 5.5 percent lower than the same week one year ago.

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 313586109